⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2011683 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL2239385 | 0.98 | EGLN1 (0.57) | — | |
| Hydrochloric Acid SCHEMBL2239390 | 0.98 | EGLN1 (0.57) | — | |
| SCHEMBL8289297 | 0.80 | — | — | |
| SCHEMBL5765192 | 0.78 | EGLN1 (0.45) | — | |
| SCHEMBL30139851 | 0.78 | EGLN1 (0.45) | — | |
| SCHEMBL12330336 | 0.77 | EGLN1 (0.35) | — | |
| SCHEMBL9362483 | 0.76 | CYP2D6 (0.55) | — | |
| SCHEMBL1647486 | 0.75 | KDM4E (0.47) | — | |
| SCHEMBL19844510 | 0.75 | EGLN1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1178788-A | Angiotensin invertase inhibitor contaiing 2 ,4 -methylene proline and its sythesis and use | SHANGHAI INST ORGANIC CHEM (CN) | 1998-04-15 | — | — | CN | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| US-4535102-A | CARBOXYLIC MONOMER WITH UNSATURATED ESTER OR OTHER VINYL COMPOUND AND ORGANIC TITANATE AND INITIATOR | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1985-08-13 | — | — | US | claimed |
| CN-119968211-A | Clostridium neurotoxin for treating bladder pain syndrome | 益普生生物制药有限公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119234152-A | Scoring method for anti-fra antibody-drug conjugate therapy | 阿斯利康(瑞典)有限公司 | 2024-12-31 | — | — | CN | disclosed |
| CN-119137279-A | Combination therapy | IP2IPO创新有限公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-119095579-A | Treatment of facial wrinkles | 益普生生物制药有限公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-118284428-A | Treatment of visceral pain | 益普生生物制药有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-117957016-A | SARS-COV-2 and influenza combined vaccine | 斯皮科纳股份有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-116438292-A | Controlling operation of a bioreactor vessel | 益普生生物制药有限公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-116406422-A | Method for producing beta-trypsin | 益普生生物制药有限公司 | 2023-07-07 | — | — | CN | disclosed |
| EP-0206362-B1 | ADHESIVE COATING MATERIAL | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1990-10-17 | — | — | EP | disclosed |
| EP-0103420-B1 | ADHESIVE COATING MATERIAL | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1989-07-19 | — | — | EP | disclosed |
| EP-0308983-A2 | NMR imaging with Mn(II) coordination compositions | SALUTAR, INC. (US) | 1989-03-29 | — | — | EP | disclosed |
| US-4766110-A | INHIBITS ANGIOTENSIN CONVERTING ENZYME, HYPOTENSIVE AGENTS | RYAN JAMES W (US) | 1988-08-23 | — | — | US | disclosed |
| EP-0206362-A1 | Adhesive coating material | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1986-12-30 | — | — | EP | disclosed |
| US-4535102-A | CARBOXYLIC MONOMER WITH UNSATURATED ESTER OR OTHER VINYL COMPOUND AND ORGANIC TITANATE AND INITIATOR | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1985-08-13 | — | — | US | disclosed |
| US-4533701-A | MIXTURE OF ADDITION COPOLYMER BASED ON A HYDROPHOBIC MONOMER AND DDICARBOXYLIC ACID AND AN ORGANIC TITANATE; DENTISTRY | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1985-08-06 | — | — | US | disclosed |
| EP-0103420-A2 | Adhesive coating material | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1984-03-21 | — | — | EP | disclosed |
| US-4377701-A | 4-Methylene-1-[[(alranoyl or arylcarbonyl)mercapto]acyl]proline and pipecolic acid | E. R. SQUIBB & SONS, INC. (US) | 1983-03-22 | — | — | US | disclosed |